NASAL MUCOSAL HYPERTROPHY

NASAL MUCOSAL HYPERTROPHY was reported 20 times

NASAL MUCOSAL HYPERTROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Leptin Analog [EPC] 1 0.0008
1 Anti-IgE [EPC] 2 0.0000
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Alkylating Drug [EPC] 2 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
5 Progestin [EPC] 1 0.0000
6 beta-Adrenergic Blocker [EPC] 1 0.0000
7 Corticosteroid [EPC] 3 0.0000
8 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
9 Platelet Aggregation Inhibitor [EPC] 1 0.0000
10 Benzodiazepine [EPC] 1 0.0000
11 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000